Jacqueline E. Shea - 15 May 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Executive Officer, Director
Signature: /s/ Jacqueline E. Shea
Issuer symbol: INO
Transactions as of: 15 May 2023
Net transactions value: $0
Form type: 4
Filing time: 17 May 2023, 16:08:41 UTC
Previous filing: 12 May 2023
Next filing: 28 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Award	$0	+638,800		$0.000000	638,800	15 May 2023	Common Stock	638,800		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	This grant was made under the 2016 Omnibus Incentive Plan.

Content

Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.

This grant was made under the 2016 Omnibus Incentive Plan.